Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis (Q34180907)

31 July 2017

1 reference

title

Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis (English)

1 reference

31 July 2017

0 references

Leo Widler

1

1 reference

31 July 2017

language of work or name

1 reference

1 April 2011

1 reference

Future Medicinal Chemistry

31 July 2017

published in

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

535-547

1 reference

Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Mechanisms of anabolic therapies for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Osteoclast-derived activity in the coupling of bone formation to resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Clinical update on teriparatide

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Teriparatide: a review of its use in osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Teriparatide in the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Developments in parathyroid hormone and related peptides as bone-formation agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Delivery of parathyroid hormone for the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Recent updates on the calcium-sensing receptor as a drug target.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Parathyroid hormone: a double-edged sword for bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Does osteocytic SOST suppression mediate PTH bone anabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Parathyroid hormone - a bone anabolic and catabolic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Calcium sensing receptor activators: calcimimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

The search for calcium receptor antagonists (calcilytics).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Emerging targets in osteoporosis disease modification

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

New aminopropandiol derivatives as orally available and short-acting calcium-sensing receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

The discovery of novel calcium sensing receptor negative allosteric modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Soft drug design: general principles and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Metabolism-guided design of short-acting calcium-sensing receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Discovery and structure-activity relationships of 2-benzylpyrrolidine-substituted aryloxypropanols as calcium-sensing receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

N(1)-Arylsulfonyl-N(2)-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: a new class of calcilytic agents acting at the calcium-sensing receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Discovery and structure-activity relationships of trisubstituted pyrimidines/pyridines as novel calcium-sensing receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Discovery tactics to mitigate toxicity risks due to reactive metabolite formation with 2-(2-hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3h)-one derivatives, potent calcium-sensing receptor antagonists and clinical candidate(s) for the t

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Design, new synthesis, and calcilytic activity of substituted 3H-pyrimidin-4-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Synthesis and antiinflammatory activity of 1-alkyl-4-aryl-2(1H)-quinazolines and quinazolinethiones

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists)

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Modeling and Mutagenesis of the Binding Site of Calhex 231, a Novel Negative Allosteric Modulator of the Extracellular Ca2+-sensing Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Improved model building and assessment of the Calcium-sensing receptor transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

A missense mutation in the seven-transmembrane domain of the human Ca2+ receptor converts a negative allosteric modulator into a positive allosteric modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

The Calcium-Sensing Receptor: A Molecular Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

The calcium-sensing receptor in normal physiology and pathophysiology: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

The functions and roles of the extracellular Ca2+-sensing receptor along the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Calcium-sensing receptor regulation of renal mineral ion transport

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Evidence in favor of a calcium-sensing receptor in arterial endothelial cells: studies with calindol and Calhex 231.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Calcium-sensing receptor in cancer: good cop or bad cop?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

The role of the calcium-sensing receptor in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Diverse roles of extracellular calcium-sensing receptor in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.11.17

21 January 2018

Identifiers

DOI

10.4155/FMC.11.17

1 reference

31 July 2017

1 reference